Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market for compounded GLP-1 RA alternatives remains strong, and some of these products are from ...

Opioid prescribing has generally decreased between 2010 and 2024, with variations based on duration of use and prescriber specialty, according to research results published in JAM ...

Clinical Advisor Director Nikki Kean sat down with Dr Leners at the American Association of Nurse Practitioners (AANP) annual ...

The transition from accelerated to traditional approval is backed by robust 24-month eGFR data from the phase 3 APPLAUSE-IgAN trial.

The CDC stated that it is "committed to working with partners to prioritize patient safety and invest in innovative strategies to further reduce health care-associated infections and protect the ...

Hypoactive sexual desire disorder is a common, underrecognized condition in women that arises from neurologic, hormonal, and ...

Researchers analyzed the impact of disease control and cumulative glucocorticoid exposure on muscle mass preservation in rheumatoid arthritis.

Drivers of uncertainty include symptom confusion and attribution, knowledge gaps, and barriers to confirmation and care ...

The headlines were everywhere – from NPR and The Washington Post to Substack and heated exchanges on social media – all ...

Researchers examined the effect of biologic therapy use on incident psoriatic arthritis among patients with psoriasis.